Amy Turner

2.3k total citations
43 papers, 1.7k citations indexed

About

Amy Turner is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Amy Turner has authored 43 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Pharmacology and 8 papers in Genetics. Recurrent topics in Amy Turner's work include Pharmacogenetics and Drug Metabolism (14 papers), Genomics and Rare Diseases (6 papers) and Muscle Physiology and Disorders (4 papers). Amy Turner is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Genomics and Rare Diseases (6 papers) and Muscle Physiology and Disorders (4 papers). Amy Turner collaborates with scholars based in United States, Spain and Canada. Amy Turner's co-authors include W. David Jarvis, Steven Grant, Rebecca S. Traylor, Lawrence F. Povirk, Ulrich Broeckel, Praful Aggarwal, Andrea Gaedigk, Kevin P. Campbell, George R. Pettit and David A. Gewirtz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Amy Turner

42 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Turner United States 21 1.1k 341 268 225 174 43 1.7k
Chung S. Song United States 29 1.1k 1.1× 324 1.0× 469 1.8× 522 2.3× 123 0.7× 44 2.2k
Konstanze Hörtnagel Germany 20 763 0.7× 550 1.6× 250 0.9× 416 1.8× 121 0.7× 39 2.0k
Michael Podvinec Switzerland 22 1.0k 1.0× 295 0.9× 371 1.4× 295 1.3× 62 0.4× 31 2.0k
Elisabetta De Marinis Italy 15 753 0.7× 122 0.4× 183 0.7× 204 0.9× 60 0.3× 27 1.3k
S Andersson United States 13 1.4k 1.3× 347 1.0× 443 1.7× 530 2.4× 169 1.0× 15 2.7k
Montserrat Barragán Spain 26 1.3k 1.2× 77 0.2× 307 1.1× 180 0.8× 233 1.3× 51 2.2k
Tetsuya Saito Japan 19 1.2k 1.1× 173 0.5× 227 0.8× 71 0.3× 221 1.3× 40 2.0k
Yasuhiro Mitsuuchi United States 24 1.9k 1.8× 244 0.7× 427 1.6× 305 1.4× 488 2.8× 37 2.9k
Anja Jaeschke United States 21 1.6k 1.5× 116 0.3× 325 1.2× 96 0.4× 277 1.6× 30 2.5k

Countries citing papers authored by Amy Turner

Since Specialization
Citations

This map shows the geographic impact of Amy Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Turner more than expected).

Fields of papers citing papers by Amy Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Turner. The network helps show where Amy Turner may publish in the future.

Co-authorship network of co-authors of Amy Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Turner. A scholar is included among the top collaborators of Amy Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Turner. Amy Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pratt, Victoria M., Larisa H. Cavallari, Andrea Gaedigk, et al.. (2024). DPYD Genotyping Recommendations. Journal of Molecular Diagnostics. 26(10). 851–863. 21 indexed citations
2.
Gaedigk, Andrea, Erin C. Boone, Amy Turner, et al.. (2023). Characterization of Reference Materials for CYP3A4 and CYP3A5. Journal of Molecular Diagnostics. 25(9). 655–664. 8 indexed citations
3.
Turner, Amy, Cyrine E. Haidar, Wenjian Yang, et al.. (2023). Updated DPYDHapB3 haplotype structure and implications for pharmacogenomic testing. Clinical and Translational Science. 17(1). e13699–e13699. 23 indexed citations
4.
Turner, Amy, et al.. (2023). Characterization of complex structural variation in the CYP2D6-CYP2D7-CYP2D8 gene loci using single-molecule long-read sequencing. Frontiers in Pharmacology. 14. 1195778–1195778. 8 indexed citations
5.
Pratt, Victoria M., Erin C. Boone, Ulrich Broeckel, et al.. (2022). Characterization of Reference Materials for TPMT and NUDT15. Journal of Molecular Diagnostics. 24(10). 1079–1088. 11 indexed citations
6.
Pratt, Victoria M., Amy Turner, Ulrich Broeckel, et al.. (2021). Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX. Journal of Molecular Diagnostics. 23(8). 952–958. 11 indexed citations
7.
Gaedigk, Andrea, Amy Turner, Robin E. Everts, et al.. (2019). Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles. Journal of Molecular Diagnostics. 21(6). 1034–1052. 54 indexed citations
8.
Yang, Jun J., Michelle Whirl‐Carrillo, Stuart A. Scott, et al.. (2018). Pharmacogene Variation Consortium Gene Introduction: NUDT15. Clinical Pharmacology & Therapeutics. 105(5). 1091–1094. 40 indexed citations
9.
Yu, Mei, Hu Zeng, Yongwei Zheng, et al.. (2017). PLCγ-dependent mTOR signalling controls IL-7-mediated early B cell development. Nature Communications. 8(1). 1457–1457. 33 indexed citations
10.
Pratt, Victoria M., Robin E. Everts, Praful Aggarwal, et al.. (2015). Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes. Journal of Molecular Diagnostics. 18(1). 109–123. 107 indexed citations
11.
Li, Wenli, Amy Turner, Praful Aggarwal, et al.. (2015). Comprehensive evaluation of AmpliSeq transcriptome, a novel targeted whole transcriptome RNA sequencing methodology for global gene expression analysis. BMC Genomics. 16(1). 1069–1069. 70 indexed citations
12.
Aggarwal, Praful, Amy Turner, Andrea Matter, et al.. (2014). RNA Expression Profiling of Human iPSC-Derived Cardiomyocytes in a Cardiac Hypertrophy Model. PLoS ONE. 9(9). e108051–e108051. 43 indexed citations
13.
Irvin, Marguerite R., C. Charles Gu, Alexander J. Stoddard, et al.. (2012). Whole-exome Sequencing and an iPSC-Derived Cardiomyocyte Model Provides a Powerful Platform for Gene Discovery in Left Ventricular Hypertrophy. Frontiers in Genetics. 3. 92–92. 16 indexed citations
14.
Beedle, Aaron M., et al.. (2012). Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy. Journal of Clinical Investigation. 122(9). 3330–3342. 49 indexed citations
15.
Satz, Jakob S., Adam P. Ostendorf, Shangwei Hou, et al.. (2010). Distinct Functions of Glial and Neuronal Dystroglycan in the Developing and Adult Mouse Brain. Journal of Neuroscience. 30(43). 14560–14572. 104 indexed citations
16.
Satz, Jakob S., Rita Barresi, Madeleine Durbeej, et al.. (2008). Brain and Eye Malformations Resembling Walker–Warburg Syndrome Are Recapitulated in Mice by Dystroglycan Deletion in the Epiblast. Journal of Neuroscience. 28(42). 10567–10575. 62 indexed citations
17.
18.
Bear, Harry D., Andrew W. McFadden, Giselle G. Hamad, et al.. (1996). Bryostatin 1 activates splenic lymphocytes and induces sustained depletion of splenocyte protein kinase C activity in vivo after a single intravenous administration. Anti-Cancer Drugs. 7(3). 299–306. 6 indexed citations
19.
Jarvis, W. David, Lawrence F. Povirk, Amy Turner, et al.. (1994). Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[β-d-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells. Biochemical Pharmacology. 47(5). 839–852. 81 indexed citations
20.
Grant, Steven, et al.. (1992). Effects of bryostatin 1 and rGM‐CSF on the metabolism of 1‐β‐d‐arabinofuranosylcytosine in human leukaemic myeloblasts. British Journal of Haematology. 82(3). 522–528. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chung S. Song Breakdown of academic impact, for papers by Konstanze Hörtnagel Breakdown of academic impact, for papers by Michael Podvinec Breakdown of academic impact, for papers by Elisabetta De Marinis Breakdown of academic impact, for papers by S Andersson Breakdown of academic impact, for papers by Montserrat Barragán Breakdown of academic impact, for papers by Tetsuya Saito Breakdown of academic impact, for papers by Yasuhiro Mitsuuchi Breakdown of academic impact, for papers by Anja Jaeschke
Rankless by CCL
2026